DSS, Inc. sells $249,408 in Impact Biomedical stock

Published 25/03/2025, 01:06
DSS, Inc. sells $249,408 in Impact Biomedical stock

DSS, Inc. (NYSE:DSS), a ten percent owner of Impact Biomedical Inc. (NASDAQ:IBO), has recently executed a series of stock transactions, according to a recent SEC filing. Impact Biomedical, currently valued at $57 million, has seen remarkable performance with a 531% return over the past week. InvestingPro analysis shows the stock’s RSI suggests overbought territory, with 12 additional exclusive insights available to subscribers. The company sold shares worth $249,408, with prices ranging from $2.90 to $4.68 per share. This significant divestiture reduced DSS’s holdings in Impact Biomedical to zero shares under the ownership of Sentinel Brokers Company, Inc., a majority-owned subsidiary of DSS.

In addition to the sales, DSS also purchased shares valued at $310, at a price of $1.55 per share, on March 20. Following these transactions, DSS continues to hold substantial shares in Impact Biomedical through its other subsidiaries, DSS BioHealth Security, Inc., DSS Securities, Inc., and DSS BlockChain Security, Inc.

In other recent news, Impact BioMedical Inc. announced the acquisition of Celios®, an air purification technology company, in an all-equity deal valued at approximately $1.15 million. This strategic move is intended to expand Impact BioMedical’s health and wellness portfolio and potentially increase its revenue. Celios® is recognized for its advanced air purification systems, which are protected by patents in the U.S. and other countries until 2043. The acquisition aligns with Impact BioMedical’s strategy to enhance its offerings in innovative health and wellness solutions.

Despite this development, Impact BioMedical has reported no significant changes in its business operations that could explain the recent volatility in its stock price. The company stated that there have been no material developments that would account for the unusual market activity, leaving investors and analysts without clear insights into the stock’s recent fluctuations. Impact BioMedical continues to focus on its mission of developing healthcare solutions while maintaining communication with its investors. The company has reminded stakeholders about the forward-looking nature of its public statements, which are subject to various uncertainties.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.